Production of IL-8, IL-17, IFN-gamma and IP-10 in human astrocytes correlates with alphavirus attenuation

Veterinary Microbiology

Volumn 163, Issue 3-4, 2013, Pages 223-234

  Peng, Bi Hung ^a   Borisevich, Viktoriya ^a   Popov, Vsevolod L ^a   Zacks, Michele A ^a   Estes, D Mark ^a,b   Campbell, Gerald A ^a   Paessler, Slobodan ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Alphavirus pathogenesis; Equine encephalitis; Viral encephalitis

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; MOUSE; NERVE CELL CULTURE; NONHUMAN; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS ATTENUATION; VIRUS ENCEPHALITIS; VIRUS REPLICATION; VIRUS VIRULENCE;

ANIMALS; ASTROCYTES; BRAIN; CELL LINE; CELL NUCLEUS; CELLS, CULTURED; CHEMOKINES; CYTOKINES; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; ENCEPHALOMYELITIS, VENEZUELAN EQUINE; FIBROBLAST GROWTH FACTORS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MICE; NUCLEOCAPSID; ZOONOSES;

ALPHAVIRUS; EQUIDAE; MURINAE; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

EID: 84875397849     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2012.11.021     Document Type: Article

References (69)

1. Alliot F., Pessac B. Astrocytic cell clones derived from established cultures of 8-day postnatal mouse cerebella. Brain Res. 1984, 306:283-291.
2. Anthony D., Dempster R., Fearn S., Clements J., Wells G., Perry V.H., Walker K. CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr. Biol. 1998, 8:923-926.
3. Audouy S., Mallet J., Privat A., Gimenez, Ribotta M. Adenovirus-mediated suicide gene therapy in an in vitro model of reactive gliosis. Glia 1999, 25:293-303.
4. Berge T.O., Banks I.S., Tigertt W.D. Attenuation of Venezuelan equine encephalomyelitis virus by in vitro cultivation in guinea pig heart cells. Am. J. Hyg. 1961, 73:209-218.
5. Biron C.A. Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr. Opin. Microbiol. 1999, 2:374-381.
6. Caccuri R.L., Iacono R.F., Weissenbacher M.C., Avila M.M., Berria M.I. Long-lasting astrocyte reaction to persistent Junin virus infection of rat cortical neurons. J. Neural Transm. 2003, 110:847-857.
7. Carlow D.A., Teh S.J., Teh H.S. Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases. J. Immunol. 1998, 161:2348-2355.
8. Chamak B., Fellous A., Glowinski J., Prochiantz A. MAP2 expression and neuritic outgrowth and branching are coregulated through region-specific neuro-astroglial interactions. J. Neurosci. 1987, 7:3163-3170.
9. Chen C.J., Chen J.H., Chen S.Y., Liao S.L., Raung S.L. Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection. J. Virol. 2004, 78:12107-12119.
10. Cheng B., Mattson M.P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron 1991, 7:1031-1041.
11. Cook D.N., Beck M.A., Coffman T.M., Kirby S.L., Sheridan J.F., Pragnell I.B., Smithies O. Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995, 269:1583-1585.
12. De Keyser J., Zeinstra E., Frohman E. Are astrocytes central players in the pathophysiology of multiple sclerosis?. Arch. Neurol. 2003, 60:132-136.
13. Demetri G.D., Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 1991, 78:2791-2808.
14. Domachowske J.B., Bonville C.A., Gao J.L., Murphy P.M., Easton A.J., Rosenberg H.F. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J. Immunol. 2000, 165:2677-2682.
15. Eddleston M., Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 1993, 54:15-36.
16. Eng L.F., Ghirnikar R.S. GFAP and astrogliosis. Brain Pathol. 1994, 4:229-237.
17. Fawcett J.W., Asher R.A. The glial scar and central nervous system repair. Brain Res. Bull. 1999, 49:377-391.
18. Fine D.L., Roberts B.A., Terpening S.J., Mott J., Vasconcelos D., House R.V. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates. Vaccine 2008, 26:3497-3506.
19. Gibson C.L., Jones N.C., Prior M.J., Bath P.M., Murphy S.P. G-CSF suppresses edema formation and reduces interleukin-1beta expression after cerebral ischemia in mice. J. Neuropathol. Exp. Neurol. 2005, 64:763-769.
20. Ireland D.D., Stohlman S.A., Hinton D.R., Atkinson R., Bergmann C.C. Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells. J. Virol. 2008, 82:300-310.
21. Jackson A.C., Rossiter J.P. Apoptotic cell death is an important cause of neuronal injury in experimental Venezuelan equine encephalitis virus infection of mice. Acta Neuropathol. 1997, 93:349-353.
22. Julander J.G., Skirpstunas R., Siddharthan V., Shafer K., Hoopes J.D., Smee D.F., Morrey J.D. C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Antiviral Res. 2008, 78:230-241.
23. Kinney R.M., Johnson B.J., Welch J.B., Tsuchiya K.R., Trent D.W. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology 1989, 170:19-30.
24. Komine-Kobayashi M., Zhang N., Liu M., Tanaka R., Hara H., Osaka A., Mochizuki H., Mizuno Y., Urabe T. Neuroprotective effect of recombinant human granulocyte colony-stimulating factor in transient focal ischemia of mice. J. Cereb. Blood Flow Metab. 2006, 26:402-413.
25. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
26. Malhotra S.K., Shnitka T.K., Elbrink J. Reactive astrocytes-a review. Cytobios 1990, 61:133-160.
27. Mattson M.P., Rychlik B. Glia protect hippocampal neurons against excitatory amino acid-induced degeneration: involvement of fibroblast growth factor. Int. J. Dev. Neurosci. 1990, 8:399-415.
28. McKeon R.J., Jurynec M.J., Buck C.R. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 1999, 19:10778-10788.
29. Miljkovic D., Momcilovic M., Stojanovic I., Stosic-Grujicic S., Ramic Z., Mostarica-Stojkovic M. Astrocytes stimulate interleukin-17 and interferon-gamma production in vitro. J. Neurosci. Res. 2007, 85:3598-3606.
30. Ni H., Yun N.E., Zacks M.A., Weaver S.C., Tesh R.B., da Rosa A.P., Powers A.M., Frolov I., Paessler S. Recombinant alphaviruses are safe and useful serological diagnostic tools. Am. J. Trop. Med. Hyg. 2007, 76:774-781.
31. Ornitz D.M., Itoh N. Fibroblast growth factors. Genome Biol. 2001, 2. REVIEWS3005.
32. Paessler S., Fayzulin R.Z., Anishchenko M., Greene I.P., Weaver S.C., Frolov I. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. J. Virol. 2003, 77:9278-9286.
33. Paessler S., Ni H., Petrakova O., Fayzulin R.Z., Yun N., Anishchenko M., Weaver S.C., Frolov I. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses. J. Virol. 2006, 80:2784-2796.
34. Paessler S., Yun N.E., Judy B.M., Dziuba N., Zacks M.A., Grund A.H., Frolov I., Campbell G.A., Weaver S.C., Estes D.M. Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection. Virology 2007, 367:307-323.
35. Park C., Lee S., Cho I.H., Lee H.K., Kim D., Choi S.Y., Oh S.B., Park K., Kim J.S., Lee S.J. TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 2006, 53:248-256.
36. Park H.K., Chu K., Lee S.T., Jung K.H., Kim E.H., Lee K.B., Song Y.M., Jeong S.W., Kim M., Roh J.K. Granulocyte colony-stimulating factor induces sensorimotor recovery in intracerebral hemorrhage. Brain Res. 2005, 1041:125-131.
37. Rezaie P., Trillo-Pazos G., Everall I.P., Male D.K. Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 2002, 37:64-75.
38. Rice C.M., Strauss J.H. Nucleotide sequence of the 26S mRNA of Sindbis virus and deduced sequence of the encoded virus structural proteins. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:2062-2066.
39. Rivas F., Diaz L.A., Cardenas V.M., Daza E., Bruzon L., Alcala A., De la Hoz O., Caceres F.M., Aristizabal G., Martinez J.W., Revelo D., De la Hoz F., Boshell J., Camacho T., Calderon L., Olano V.A., Villarreal L.I., Roselli D., Alvarez G., Ludwig G., Tsai T. Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J. Infect. Dis. 1997, 175:828-832.
40. Roehrig J.T., Bolin R.A. Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of Subtype I Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay. J. Clin. Microbiol. 1997, 35:1887-1890.
41. Rosenberg P.A., Aizenman E. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett. 1989, 103:162-168.
42. Rutella S., Rumi C., Sica S., Leone G. Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): effects on lymphocyte phenotype and function. J. Interferon Cytokine Res. 1999, 19:989-994.
43. Schneider A., Kruger C., Steigleder T., Weber D., Pitzer C., Laage R., Aronowski J., Maurer M.H., Gassler N., Mier W., Hasselblatt M., Kollmar R., Schwab S., Sommer C., Bach A., Kuhn H.G., Schabitz W.R. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 2005, 115:2083-2098.
44. Schoneboom B.A., Catlin K.M., Marty A.M., Grieder F.B. Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice. J. Neuroimmunol. 2000, 109:132-146.
45. Schoneboom B.A., Fultz M.J., Miller T.H., McKinney L.C., Grieder F.B. Astrocytes as targets for Venezuelan equine encephalitis virus infection. J. Neurovirol. 1999, 5:342-354.
46. Shaftel S.S., Carlson T.J., Olschowka J.A., Kyrkanides S., Matousek S.B., O'Banion M.K. Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration. J. Neurosci. 2007, 27:9301-9309.
47. Shapiro S., Miller A., Lahat N., Sobel E., Lerner A. Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis. J. Neurol. Sci. 2003, 206:43-48.
48. Sheibani N., Grabowski E.F., Schoenfeld D.A., Whalen M.J. Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice. Crit. Care Med. 2004, 32:2274-2278.
49. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
50. Solaroglu I., Cahill J., Jadhav V., Zhang J.H. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 2006, 37:1123-1128.
51. Solaroglu I., Tsubokawa T., Cahill J., Zhang J.H. Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat. Neuroscience 2006, 143:965-974.
52. Steele K.E., Davis K.J., Stephan K., Kell W., Vogel P., Hart M.K. Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H/HeN and BALB/c mice. Vet. Pathol. 1998, 35:386-397.
53. Stitt T.N., Hatten M.E. Antibodies that recognize astrotactin block granule neuron binding to astroglia. Neuron 1990, 5:639-649.
54. Strauss E.G., Strauss J.H. Structure and replication of the alphavirus genome. The Togaviruses and Flaviviruses 1986, 35-90. Plenum Press, New York. S. Schlesinger, M. Schlesinger (Eds.).
55. Strauss J.H., Calisher C.H., Dalgarno L., Dalrymple J.M., Frey T.K., Pettersson R.F., Rice C.M., Spaan W.J.M. Togaviridae. Virus Taxonomy. Sixth Report of the International Committee on Taxonomy of Viruses 1995, 428-433. Springer-Verlag, New York. F.A. Murphy, C.M. Fauquet, D.H.L. Bishop, S.A. Ghabrial, A.W. Jarvis, G.P. Martelli, M.A. Mayo, M.D. Summers (Eds.).
56. Strauss J.H., Strauss E.G. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 1994, 58:491-562.
57. Taylor G.A., Collazo C.M., Yap G.S., Nguyen K., Gregorio T.A., Taylor L.S., Eagleson B., Secrest L., Southon E.A., Reid S.W., Tessarollo L., Bray M., McVicar D.W., Komschlies K.L., Young H.A., Biron C.A., Sher A., Vande Woude G.F. Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proceedings of the National Academy of Sciences of the United States of America 97 2000, 751-755.
58. Taylor G.A., Jeffers M., Largaespada D.A., Jenkins N.A., Copeland N.G., Woude G.F. Identification of a novel GTPase, the inducibly expressed GTPase, that accumulates in response to interferon gamma. J. Biol. Chem. 1996, 271:20399-20405.
59. Trifilo M.J., Lane T.E. The CC chemokine ligand 3 regulates CD11c+CD11b+CD8alpha- dendritic cell maturation and activation following viral infection of the central nervous system: implications for a role in T cell activation. Virology 2004, 327:8-15.
60. Vibulsreth S., Hefti F., Ginsberg M.D., Dietrich W.D., Busto R. Astrocytes protect cultured neurons from degeneration induced by anoxia. Brain Res. 1987, 422:303-311.
61. Walton T.E., Grayson M.A. Venezuelan equine encephalomyelitis. The Arboviruses: Epidemiology and Ecology, Vol. IV 1988, 203-231. CRC Press, Boca Raton, FL. T.P. Monath (Ed.).
62. Wang E., Barrera R., Boshell J., Ferro C., Freier J.E., Navarro J.C., Salas R., Vasquez C., Weaver S.C. Genetic and phenotypic changes accompanying the emergence of epizootic subtype IC Venezuelan equine encephalitis viruses from an enzootic subtype ID progenitor. J. Virol. 1999, 73:4266-4271.
63. Weaver S.C., Ferro C., Barrera R., Boshell J., Navarro J.C. Venezuelan equine encephalitis. Annu. Rev. Entomol. 2004, 49:141-174.
64. Weaver S.C., Salas R., Rico-Hesse R., Ludwig G.V., Oberste M.S., Boshell J., Tesh R.B. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America. Lancet 1996, 348:436-440.
65. Williams A., Piaton G., Lubetzki C. Astrocytes-friends or foes in multiple sclerosis?. Glia 2007, 55:1300-1312.
66. Young N.A. Serologic differentiation of viruses of the Venezuelan encephalitis (VE) complex. Proc. Workshop-Symposium on Venezuelan Encephalitis Virus 1972, 84-89. Pan American Health Organization, Washington, DC.
67. Young N.A., Johnson K.M. Antigenic variants of Venezuelan equine encephalitis virus: their geographic distribution and epidemiologic significance. Am. J. Epidemiol. 1969, 89:286-307.
68. Zavala F., Abad S., Ezine S., Taupin V., Masson A., Bach J.F. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J. Immunol. 2002, 168:2011-2019.
69. Zhao Z., Alam S., Oppenheim R.W., Prevette D.M., Evenson A., Parsadanian A. Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy. Exp. Neurol. 2004, 190:356-372.